Novo Nordisk sues Eli Lilly for false ads

Novo Nordisk has filed a lawsuit against Eli Lilly in the US, alleging false advertising related to their weight-loss drugs. The Danish company claims Eli Lilly's ad campaigns falsely suggest their medications are superior by comparing outdated studies and omitting recent, higher-dose options. Novo seeks a court order to stop Lilly's ads and replace them with accurate information reflecting current clinical evidence.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل